Cargando…
Chimeric Antigen Receptor T-Cell Therapy: The Light of Day for Osteosarcoma
SIMPLE SUMMARY: As a novel immunotherapy, chimeric antigen receptor (CAR) T-cell therapy has achieved encouraging results in leukemia and lymphoma. Furthermore, CAR-T cells have been explored in the treatment of osteosarcoma (OS). However, there is no strong comprehensive evidence to support their e...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431424/ https://www.ncbi.nlm.nih.gov/pubmed/34503279 http://dx.doi.org/10.3390/cancers13174469 |